Quantcast
Close Window
   
WARNING:
Hello,
You are about to enter the largest, most comprehensive web site dedicated to exposing and ending corruption at Johnson & Johnson and subsidiaries that allows known risky, if not downright harmful, products to reach our healthcare system.
 
Reached goal of 1 MILLION page views!
 
This site has had visitors from the servers of:
(Link to list: Notable Visitors)
- US SENATE
- World Health Organization
- National Health Service UK
- US Centers for Disease Control
- Department of Defense
- Department of Justice
- US Federal Reserve

- Ernst & Young
- Group M (world's largest media investment group)
- Young & Rubicam PR FIRM
- Porter Novelli PR FIRM
- Grey Group PR FIRM
- CBS
- offices of the DOW
- Morgan Stanley
- Deutsche Bank
- JPMorgan
- CitiGroup
- The Bank of New York Mellon Corp
- Lloyds Banking Group PLC
- Cantor Fitzgerald & Co.
- Harris Trust & Savings Bank
- BlackRock Financial Management
- The Capital Group
- RBS Securities in US
- Bank of America

- India Institute of Management
- Quinnipiac University
- Universitaet Graz
- Baruch College
- University of North Carolina at Chapel Hill
- University of North Carolina at Greensboro
- Lancaster University
- Yale
- Miami Dade College
- Marymount Manhattan College
- Loyola University
- Punjabi University
- Franciscan University
- Arizona State University
- University of Surrey London
- Loughborough University
- Southern University at New Orleans
- Amrita Vishwa Vidyapeetham University
- Northern Caribbean University
- Louisiana State University
- Hong Kong University of Science and Technology
- Oregon State University
- University of California
- Rutgers University
- Southern New Hampshire University
- Vanderbuilt University
- Macquarie University
- CRI Universite de Nantes - 2 Rue de la Houssiniere
- International Islamic University Of Malaysia
- Baylor University
- Taiwan Academic Network (TANet) Information Center
- Suffolk University
- Pittsburg State University
- Idaho State University
- University of Miami
- University of Hawaii
- University of Colorado
- Duke University
 
Thank you for your visit,
Emily
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Will you PLEASE help?
 
Mission Statement
Web site effort of HOMELESS woman to expose Johnson & Johnson harmful products and corruption
REACHED MILESTONE OF 1 MILLION PAGE VIEWS!
 
If you believe in this project, please help support this work for global health and safety of Johnson & Johnson subsidiary products.
 
Notable visitors in the last 5 days included Johnson & Johnson, Southern New Hampshire University, Marist College, Morgan Stanley. Visitors came from all over the world including: Germany, Israel, Austria, Canada, China, Korea, United Kingdom, Ireland, the Netherlands, India, Sweden, Brazil, Kuwait, Belgium, Australia, Spain, Philippines and Mexico.
 
Page views February 3, 2016: 1,872 / 10 hrs
Page views February 4, 2016: 2,482 / 10 hrs
Page views February 5, 2016: 2,394 / 15 hrs
Page views February 6, 2016: 3,507 / 8 hrs
Page views February 7, 2016: 2,407 / 8 hrs
Total page views since last gift: 12,662 / 50 hrs
Gifts since last count start: $5.00 from the Netherlands - Thank You!
A few CENTS an hour as compared to Gorsky's $47.00 a SECOND for hurting people like YOU for profit.
No wonder I'm in homeless hell.
Need a bit more support, eh? How about YOU help a little?
 
Without support, I can't run the site, do all the research, content development and sharing.
If I give up due to massive lack of support, who is going to do all this work to keep up the fight for YOU?
Remember, these are YOUR products, too. Products for your loved ones, your children, your parents, your friends. You might want them to be safe.
 
Thank you for your help.
Emily
$.00   
 

Expose the corrupt management individuals at Johnson & Johson so they can be held accountable for the hundreds of thousands of victims of Johnson & Johnson and subsidiary companies around the world and put an end to the flow of harmful healthcare products.
 
The FDA is NOT ensuring product safety, management is making too much money in kickbacks and bullying FDA scientists into approving products that should never have been approved.
 
Our pathetic US SENATE HELP COMMITTEE is NOT doing their job either. What I have done for this site is THEIR job, and obviously they are making too much money ignoring harm by pharmaceutical products to do anything about the harm being caused to consumers.
 
Media is keeping their mouth shut and turning a blind eye as well. Most media is not going to risk the loss of billions of dollars made advertising Johnson & Johnson harmful products. It would mean financial ruin.
TVTMesh
ASRHips
Uterine Morcellators
Levaquin
Risperdal
Xarelto
Nucynta
 
Baby Tylenol
Baby Powder
Splenda
Contact Lenses
Circular Staplers
Diabetic Glucose Monitors
and more....
Johnson & Johnson Consumer Sales Continue to Drop, 2011 to 2013
Johnson & Johnson consumer goods sales continue to slide in 2013 due to boycotts, recalls and more carcinogens in baby care products.

Keywords: jnj, johnson and johnson, johnson & johnson, J&J, boycott, recall, baby, products
Date Created/Edited: 2013, May 12
 


 
Recent Content
Asthma Rates Reduce After Toxic Chems Removed from Baby Products Twenty years of activism truly paying off. With known harmful ingredients removed from Johnson & Johnson baby 'care' products, childhood asthma rates starting to decline.
 
Alexander Law Group, LLP Wins $70 Million Punitive Judgment Against Johnson & Johnson Subsidiary Ethicon Endo-Surgery $9.8 Million in Compensatory Damages Levied by Jury Last Week
 
The REAL Reason for High Healthcare Product Prices US Senators claim they are investigating the reason for such outrageous drug prices. Uh, gee, not so hard to figure out...
 
Michelle Obama and the Johnson & Johnson CEO Gorsky $5 Billion Risperdal, Omnicare, Medicaid Scandal Hey-uh, when Johnson & Johnson Janssen was illegally funneling money out of Medicaid through Omnicare for Risperdal - Uh, Michelle was HOSPITAL ADMINISTRATOR in Chicago, where original case broke.
 
How Johnson & Johnson is Screwing Their Institutional Shareholders Multiply number of shares by $3. Subtract 50% of foreclosure losses, 60% of bankruptcies, percentage of loan defaults due to injuries caused by a Johnson & Johnson or subsidiary product. Hm. Probably looks like Johnson & Johnson crappy products are costing your financial instituation a LOT of money ;o)
 
Risperdal US DEATH Warning for Elderly Dementia NOT Applied in AU Q to Alex Gorsky, Chairman/CEO of Johnson and Johnson, would you give your USA banned drug Risperdal to your father, if he had dementia?
 
United States Senate HELPless Committee The US Senate Committee on Health, Education, Labor and Pensions is supposed to be looking out for best interest of voters, but seems to be taking cash from BOTH sides and protecting corruption at Johnson & Johnson and Obama administration.
 
List of Interesting Visitors to the Johnson and Toxin web site (colleges, universities, law firms, journalists, financial institutions,...)
Please read:
2015 Consumer Letter to Johnson & Johnson Shareholders
 
Honoring Request to Say Something Nice About Johnson & Johnson
 
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500.
 
Numerous groups have called for boycotts of Johnson & Johnson products for a variety of reasons. In addition, as more mothers in the United States are educated regarding known carcinogens in the U.S. formulation of baby soap, shampoo, powder, lotions, creams and other baby products as well as the same carcinogens in adult care products, it is obvious that the sales of J&J toxic consumer products are suffering as consumers choose less toxic products.
 
2011 : 2011 consumer sales : U.S. decrease 6.7% / Int increase 7.3 / WW increase 2.0%
http://www.investor.jnj.com/2011annualreport/pdf/JNJ-2011_ManagementsDiscussion_AnalysisSales.pdf page 2 of 11
 
2012 : 1st quarter consumer sales : U.S. decrease 2.2% / Int decrease 2.5% / WW decrease 2.4%
Worldwide Consumer sales of $3.6 billion for the first quarter represented a decrease of 2.4% versus the prior year consisting of an operational decline of 0.6% and a negative impact from currency of 1.8%. Domestic sales decreased 2.2%. International sales decreased 2.5%, which reflected an operational increase of 0.4% and a negative currency impact of 2.9%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-first-quarter-results
 
2012 : 2nd quarter consumer sales : U.S. decrease 1.9% / Int decrease 6.0% / WW decrease 4.6%
Worldwide Consumer sales of $3.6 billion for the second quarter represented a decrease of 4.6% versus the prior year consisting of an operational increase of 0.6% and a negative impact from currency of 5.2%. Domestic sales decreased 1.9%. International sales decreased 6.0%, which reflected an operational increase of 2.0% and a negative currency impact of 8.0%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-second-quarter-results
 

2012 : 3rd quarter consumer sales : U.S. decrease 4.3% / Int decrease 6.1% / WW decrease 4.3%
Worldwide Consumer sales of $3.6 billion for the third quarter represented a decrease of 4.3% versus the prior year consisting of an operational increase of 1.0% and a negative impact from currency of 5.3%. Domestic sales decreased 0.4%. International sales decreased 6.1%, which reflected an operational increase of 1.8% and a negative currency impact of 7.9%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-third-quarter-results
 
2012 : full year consumer sales : U.S. decrease 2% / Int decrease 3.4% / WW decrease 2.9%
Worldwide Consumer sales of $14.4 billion for the full-year 2012 represented a decrease of 2.9% versus the prior year, consisting of an operational increase of 0.5% and a negative impact from currency of 3.4%. Domestic sales decreased 2.0%; international sales decreased 3.4%, which reflected an operational increase of 1.9% and a negative currency impact of 5.3%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-fourth-quarter-and-full-year-results
 
With yet another recall of Children's Tylenol and yet another undisclosed carcinogen found in yet another baby care product, I don't see Johnson & Johnson consumer sales rebounding any time soon. I don't know, maybe people don't want to risk using products on their children that might harm their precious babies. As people like me continue sharing the risks as fast as we can with other moms so they don't use toxic products, I think sales will likely continue to drop.
 
Something to consider: As fewer people use toxic products from Johnson & Johnson, the rate of long-term illnesses, such as asthma, allergies, chronic sinus infections, COPD, cancer, low fertility, and such, caused by these products (and the drugs prescribed to deal with side effects of the drugs prescribed) will begin to decline - cutting into Johnson & Johnson medical devices and pharmaceuticals sales ;o)
 
Resources:
1. Elizabeth Lopatto (2013, May 3). J&J Recalls Some Children’s Tylenol in South Korea Bloomberg. Retrieved from http://www.bloomberg.com/news/2013-05-03/j-j-recalls-some-children-s-tylenol-in-south-korea.html
 
2. Ganesh N (2013, April 25). FDA suspends J&J Licence New indian Express. Retrieved from http://www.newindianexpress.com/nation/FDA-suspends-JJ-Licence/2013/04/25/article1560077.ece
 
 
 
 
 
 
 
 
 
All contents Copyright © 2012-2016 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries